Table 2

Prevalence of anti-SRCR and anti-SR-A IgG in patients and healthy controls

Anti-SRCR positive (%)

Anti-SR-A positive (%)

Double positive (%)


Healthy control (n = 85)

0

0

0

SLE (n = 65)

18.5*

33.8*

7.7

RA (n = 65)

3.1§

13.8*

0

pSS (n = 25)

0

12.0*

0


* P < 0.001 as compared with healthy controls.

P = 0.014 as compared with healthy controls.

§ P = 0.186 as compared with healthy controls.

pSS, primary Sjögren syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SR-A, scavenger receptor A; SRCR, scavenger receptor cysteine-rich.

Chen et al. Arthritis Research & Therapy 2011 13:R9   doi:10.1186/ar3230

Open Data